Developer of a dental artificial intelligence platform designed to empower dental payers and providers to deliver better
Developer of a dental artificial intelligence platform designed to empower dental payers and providers to deliver better patient care.
Enterprise Systems (Healthcare)📍 Boston, MAFounded 2018
Current Valuation
$550M
as of 2024-Q1
PRIVATE
QL Price
$357.47M
-35% vs last round
QuantLogix's current estimate for Overjet, published 2026-09-27 — below the last disclosed round of $550M (2024-Q1).
Confidence
medium
Basis
secondary led
What backs this price
Last disclosed round
$550M
2024-Q1
weight 0.18
Secondary market print
$298.1M
2026-06-27
weight 0.58
How this price has held up
No round has priced for Overjet since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, Overjet, 2026-09-27 (edcb19dd42bb59d4).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is Overjet going public?
No. Overjet is private and has not filed to go public. There is no S-1 on file.
What is Overjet's valuation in 2026?
Overjet is valued at $550M as of 2024-Q1, set by its Series C ($56.72M, Mar 2024). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Overjet filed an S-1?
No public S-1 is on file for Overjet.
How much has Overjet raised?
Overjet has raised $134.29M in total, most recently a Series C of $56.72M in Mar 2024.
Is Overjet publicly traded — can you buy Overjet stock?
No. Overjet is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Overjet on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2018
HQ
Boston, MA
Employees
180
Total Raised
$134.29M
Last Round
Series C — $56.72M (Mar 2024)
IPO Status
private
Fundraising Status
Series C · $56.72M · 2y 6mo ago
privateTotal raised $134.29M
Secondary Market
Implied price / share
$13.68
Last round price / share
$25.23
vs last round
-45.8%
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series C
$56.72M
Mar 2024
—
$550M
Talent Signal
Hiring trend
▲ Hiring uptrend
+16% vs 2026-08
Open roles
22
via ashby
Product-build share
23%
engineering, research, product, design
Trajectory
expanding
go-to-market push — Only 23% of open roles build product — hiring is concentrated in sales/marketing/ops (10 of 22 open roles are sales).
No tracked executive churn; open roles trending up.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Lead Product Manager, New ProductDirector of Engineering, New ProductsTechnical Support Engineering ManagerHead of Product, New ProductsStaff Software EngineerTalent Pool at Overjet
Counted from Overjet's live job board as of 2026-09-17; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Health Care
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2024-Q1. Refreshed quarterly.